One of the most striking findings was this: about 62% of marijuana users reported engaging in physical activity three or more times per week, while only 13% admitted to consuming fast food at the same frequency. These numbers suggest that the average cannabis consumer is far more likely to be found on a jogging trail or in a yoga studio than in a drive-thru line.

Since the dawn of legal adult-use marijuana markets in 2014, U.S. states have collectively generated nearly $25 billion in tax revenue from cannabis sales, marking a transformative milestone in the nation’s approach to cannabis policy and public finance. A recent report by the Marijuana Policy Project (MPP) reveals that in 2024 alone, states with legalized adult-use cannabis collected more than $4.4 billion in tax revenue—the highest annual total recorded to date.

A new and very dangerous form of cannabis, called “kush,” is causing serious problems around the world. But this isn’t the normal cannabis people know. This kush is a scary mix of cannabis, fentanyl (a very strong opioid), tramadol, formaldehyde, and even ground-up human bones. This deadly combination is hurting many people, especially in West Africa, and it’s now spreading to other countries, including the UK.

Cannabis pouches, particularly those containing cannabidiol (CBD), are an emerging product category that mirrors the form factor and convenience of nicotine pouches. CBD, a non-intoxicating cannabinoid, is increasingly sought after for its potential therapeutic benefits, including stress relief, relaxation, and pain management.

The cannabis industry is now a major job generator, responsible for the creation of more than 440,000 full-time roles just last year. That’s more than a 5% jump from the previous year, which shows how the cannabis industry has recovered well from the pandemic.

Looking ahead, the German cannabis market is projected to expand substantially. Estimates suggest that by 2025, the market could generate revenues exceeding 1 billion US dollars (approximately 930 million euros), with forecasts anticipating a market size of €4.6 billion by 2034[1][3]. This growth will be fueled by further legalization steps, increased domestic cultivation, and the introduction of pilot retail programs in cities like Frankfurt and Hannover.

In a significant legal decision that could impact millions of Americans, a federal judge recently ruled that insurance companies are not obligated to cover the cost of medical marijuana, even when prescribed by a licensed physician. This ruling exposes the complicated, often contradictory relationship between state-level legalization of cannabis and federal law, and it leaves many patients in a precarious situation: forced to either absorb the often high cost of their treatment or go without it altogether.

The current administration can make or break the way for cannabis rescheduling. When Biden’s administration proposed making cannabis a Schedule III drug, it was a pivotal yet incomplete move – more needed to be done in order to legalize cannabis in the eyes of the federal law and get it on the same page as state-level legalization.

A surprising shift has caught the eye of analysts and regulators: a European company has managed to saturate the U.S. market with cannabis seeds, doing so legally and efficiently by leveraging strategic tactics, innovative logistics, and a savvy grasp of international and federal legal loopholes.

The study seeks to recruit 2,000 adults across legal cannabis states in the U.S. to participate in a three-week research program designed to capture real-world data on the effects of THC beverages compared to alcohol.